Please try another search
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. The company’s lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer’s disease. It has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Jack Antel | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Michael Davis | - | 2020 | Advisor |
George Perry | 71 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Randall E. Kaye | 62 | 2020 | Independent Director |
Reisa Sperling | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Anneke Van Der Walt | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Jeffrey K. Cohen | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Robert W. Naismith | 79 | 2021 | Multiple Sclerosis Clinical Advisory Board |
Krista L. McKerracher | - | 2021 | Independent Director |
Michael A. Weiner | 77 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Jeremy Chataway | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Brian Eric Bayley | 71 | 2018 | Independent Director |
Jeffrey L. Cummings | 74 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Jerry Silver | - | - | Co-Inventor & Scientific Advisor |
Henrik Zetterberg | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Martin Rhys Farlow | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Bruce Lamb | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Brian Kwon | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Linda Jones | - | - | Member of Clinical Spinal Cord Injury Advisory Board |
Michael Kelly | 58 | 2023 | CEO, President & Director |
James Guest | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
John Craig Thompson | - | 2022 | Independent Director |
Gianni Ruffolo | - | 2023 | Independent Director |
Steven Kirshblum | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Adam H. Rogers | - | 2022 | Director |
Glenn Antony Ives | 60 | 2021 | Chairman |
Daniel P. Lammertse | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Brian McAlister | - | - | Co-Founder & Advisor |
Harold Martin Punnett | - | 2017 | Co-Founder & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review